Exchange: NASDAQ·Updated 07:40 PM EDT

About

Attovia Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing next-generation biotherapeutics for immune-mediated diseases. It delivers treatments through its platform, ATTOBODY. The company was founded by Tao Fu, Zaneta Odrowaz, and Petter Veiby on December 16, 2022 and is headquartered in San Carlos, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Attovia Therapeutics Inc.?
What is the 52-week high for Attovia Therapeutics Inc.?
What is the 52-week low for Attovia Therapeutics Inc.?
What is Attovia Therapeutics Inc. stock price today?
What was Attovia Therapeutics Inc. stock price yesterday?
What is the Price-to-Book ratio of Attovia Therapeutics Inc.?
What is the 50-day moving average of Attovia Therapeutics Inc.?

Advertisement|Remove ads.